Exicure (XCUR) Depreciation & Amortization (CF) (2016 - 2026)
Exicure (XCUR) reported Depreciation & Amortization (CF) of $49000.0 for Q1 2026, down 19.67% on a YoY basis from $61000.0 in Q1 2025, and up 75.0% quarter-over-quarter from $28000.0 in Q4 2025.
Exicure (XCUR) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends
Exicure has reported Depreciation & Amortization (CF) for 11 years, with the latest figure at $49000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 19.67% year-over-year to $49000.0; the trailing twelve-month figure through Mar 2026 stood at $230000.0 (up 180.49% YoY), and the FY2025 full-year result was $242000.0, up 764.29% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $49000.0, up from $28000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $302000.0 in Q1 2022, with the low at $7000.0 in Q4 2023.
- Historically, Depreciation & Amortization (CF) has averaged $124470.6 across 5 years, with a median of $71000.0 in 2025.
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) sank 97.51% — and 2025, when it jumped 1071.43%.
- Exicure's Depreciation & Amortization (CF) stood at $281000.0 in 2022, then slumped by 97.51% to $7000.0 in 2023, then changed by 0.0% to $7000.0 in 2024, then jumped by 300.0% to $28000.0 in 2025, then jumped by 75.0% to $49000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $49000.0 (Q1 2026), $28000.0 (Q4 2025), and $82000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 429,663.65 |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | 49,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49,000.00 |
| Mar 31, 2026 | 49,000.00 |
| Dec 31, 2025 | 28,000.00 |
| Dec 31, 2025 | 28,000.00 |
| Sep 30, 2025 | 82,000.00 |
| Sep 30, 2025 | 82,000.00 |
| Jun 30, 2025 | 71,000.00 |
| Jun 30, 2025 | 71,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Dec 31, 2023 | 7,000.00 |